Literature DB >> 12679431

Lower neonatal screening thyroxine concentrations in down syndrome newborns.

A S P van Trotsenburg1, T Vulsma, H M van Santen, W Cheung, J J M de Vijlder.   

Abstract

There is an unexplained higher incidence of congenital hypothyroidism (CH) detected by T(4)-based neonatal screening programs and a very high prevalence of (mild) plasma TSH elevation in young children with Down syndrome (DS). To determine whether newborns with DS have decreased blood T(4) concentrations at the time of the neonatal screening, we conducted an observational study in a large and representative cohort of Dutch children with DS born in 1996 and 1997. CH screening results (T(4), TSH, and T(4)-binding globulin concentrations) were analyzed in comparison with clinical information obtained by interviewing the parents and data from the general newborn population and a large control group. The mean T(4) concentration of the studied children with DS (n = 284) was significantly decreased. The individual T(4) concentrations were normally (Gaussian) distributed but shifted to lower concentrations. This could not be explained by prematurity, nonthyroidal illness, or iodine exposure. Mean TSH and T(4)-binding globulin concentrations were significantly increased and normal, respectively. The decreased T(4) concentration, left-shifted normal distribution, and mildly elevated TSH concentrations point to a mild hypothyroid state in newborns with DS and support the existence of a DS-specific thyroid (regulation) disorder. The question remains whether this contributes to the brain maldevelopment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679431     DOI: 10.1210/jc.2002-021303

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Characterization of Thyroid Abnormalities in a Large Cohort of Children with Down Syndrome
.

Authors:  Melinda J Pierce; Stephen H LaFranchi; Joseph D Pinter
Journal:  Horm Res Paediatr       Date:  2017-03-03       Impact factor: 2.852

2.  The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.

Authors:  Faycal Guedj; Jeroen L A Pennings; Millie A Ferres; Leah C Graham; Heather C Wick; Klaus A Miczek; Donna K Slonim; Diana W Bianchi
Journal:  Am J Med Genet A       Date:  2015-05-14       Impact factor: 2.802

Review 3.  Pediatric Hypothyroidism: Diagnosis and Treatment.

Authors:  Ari J Wassner
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

4.  Longitudinal study of thyroid function in Down's syndrome in the first two decades.

Authors:  P A Gibson; R W Newton; K Selby; D A Price; K Leyland; G M Addison
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

5.  Congenital anomalies in infant with congenital hypothyroidism.

Authors:  Zahra Razavi; Alireza Yavarikia; Saadat Torabian
Journal:  Oman Med J       Date:  2012-09

Review 6.  Thyroid dysfunction in children with Down syndrome: a literature review.

Authors:  K King; C O'Gorman; S Gallagher
Journal:  Ir J Med Sci       Date:  2013-08-10       Impact factor: 1.568

7.  Profile of hypothyroidism in Down's syndrome.

Authors:  Ayşe Nurcan Cebeci; Ayla Güven; Metin Yıldız
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

8.  European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.

Authors:  Juliane Léger; Antonella Olivieri; Malcolm Donaldson; Toni Torresani; Heiko Krude; Guy van Vliet; Michel Polak; Gary Butler
Journal:  J Clin Endocrinol Metab       Date:  2014-01-21       Impact factor: 5.958

9.  Revisiting early hypothyroidism screening in infants with Down syndrome.

Authors:  I B Purdy; N Singh; W L Brown; S Vangala; U P Devaskar
Journal:  J Perinatol       Date:  2014-06-19       Impact factor: 2.521

10.  Metamorphic thyroid autoimmunity in Down Syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond.

Authors:  Tommaso Aversa; Mariella Valenzise; Mariacarolina Salerno; Andrea Corrias; Lorenzo Iughetti; Giorgio Radetti; Filippo De Luca; Malgorzata Wasniewska
Journal:  Ital J Pediatr       Date:  2015-11-11       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.